January 2025 Br J Cardiol 2025;32:36 doi:10.5837/bjc.2025.002
Sheona McHale, Alice Pearsons, Coral Hanson, Mary McAuley, Maggie Simpson, Carol Porteous, Val Irvine, Roisin Houston, Paula Henderson, Lis Neubeck
Abstract
Introduction
Cardiovascular disease (CVD) is the leading cause of death and disability globally, accounting for 32% of all global deaths in 2019, of which 85% were due to myocardial infarction (MI) and stroke.1 CVD and associated circulatory conditions are the most common cause of premature death in the UK, and are estimated to cost the National Health Service (NHS) £9 billion each year.2 In Scotland, it is estimated that 700,000 people are living with CVD, resulting in NHS costs of approximately £800 million per year.2 Research in CVD has been critical to improving cardiovascular outcomes over the past three decades.3 Identifying what rese
|
Full text
